Jonathan R. Goodman, Director at POINT Biopharma Global Inc. (PNT), bought 6,000 shares at $6.33 ($38K) on 2022-11-18, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.